scispace - formally typeset
C

C. B. Guedes

Publications -  7
Citations -  28

C. B. Guedes is an academic researcher. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 3, co-authored 7 publications receiving 28 citations.

Papers
More filters
Journal ArticleDOI

High levels of NRF2 sensitize temozolomide-resistant glioblastoma cells to ferroptosis via ABCC1/MRP1 upregulation

TL;DR: In this article , the role of NRF2 in ferroptosis modulation in glioblastoma cells was analyzed, and it was shown that high levels of NN2 result in collateral sensitivity on glioma via the expression of its pro-ferroptotic target ABCC1 , which contributes to GSH depletion when the system xc − is blocked by Erastin.
Journal ArticleDOI

Ferroptosis Modulation: Potential Therapeutic Target for Glioblastoma Treatment

TL;DR: An overview of the mechanisms of the iron-dependent cell death and the current findings of ferroptosis modulation on glioblastoma including its non-canonical pathway are presented and focused on new ferroPTosis-inducing compounds for glioma treatment.
Journal ArticleDOI

Human tumor necrosis factor alpha affects the egg-laying dynamics and glucose metabolism of Schistosoma mansoni adult worms in vitro

TL;DR: In this article , the effects of human tumor necrosis factor alpha (hTNF-α) on Schistosoma mansoni egg-laying in vitro were investigated. And they found that crosstalk involving hTNF and parasite signaling plays a role in the fine-scale regulation of the worm's metabolism and physiology, and points to new strategies for disease control.
Journal ArticleDOI

Human tumor necrosis factor alpha affects the egg-laying dynamics and glucose metabolism of Schistosoma mansoni adult worms in vitro

TL;DR: In this paper , the effects of human tumor necrosis factor alpha (hTNF-α) on Schistosoma mansoni egg-laying in vitro were investigated. And they found that crosstalk involving hTNF and parasite signaling plays a role in the fine-scale regulation of the worm's metabolism and physiology, and points to new strategies for disease control.
Journal ArticleDOI

Temozolomide Resistance in Glioblastoma by NRF2: Protecting the Evil

TL;DR: In this paper , a review highlights the research that is demonstrating how NRF2 hyperactivation creates an environment that favors the survival of malignant cells and protects against oxidative stress and TMZ.